Telescope Innovations to Attend Fastmarkets Global Lithium, Battery & Critical Materials in Las Vegas
June 23, 2026 — The Company will use the conference to advance commercial discussions around Self-Driving Labs, automated sampling systems, and lithium sulfide materials licensing
Telescope Innovations Provides Financial Results of Third Fiscal Quarter 2026
June 16, 2026 — Year-to-date revenues are 80% higher than comparative values for previous fiscal year.
Telescope Innovations to Present at the Planet MicroCap Las Vegas Powered by MicroCapClub
June 11, 2026 — Telescope will discuss DirectInject-LC™, a newly announced technology development collaboration with AGI SDA, and the Company’s Self-Driving Lab deployments.
Telescope Innovations Founder and CTO, Professor Jason Hein, Receives 2026 SCI Canada LeSueur Memorial Award
June 5, 2026 — Jason’s recognition with the LeSueur Memorial Award is a testament to the caliber of scientific leadership at the heart of Telescope.
Telescope Innovations Secures Third Self-Driving Lab Deployment with Major Global Pharmaceutical Company
June 1, 2026 — Continued adoption by world-leading pharmaceutical partners underscores growing industry demand for autonomous lab technology
Telescope Innovations Shares Spring 2026 Conference and Events Lineup
May 11, 2026 — The Company is actively engaging with pharmaceutical, academic, and investor audiences to strengthen existing and novel partnerships
Curzio Research Interviews Telescope CTO
April 20, 2026 — CTO Jason Hein tells Frank Curzio how our young company is changing the way Big Pharma performs R&D.
Telescope Innovations Provides Financial Results of Second Fiscal Quarter 2026
April 13, 2026 — Revenues are consistent with budget expectations and ahead of Q2 2025 comparative revenues.
Telescope Innovations Announces Expansion of Consulting Role for Dr. Joel M. Hawkins, Industry Leader in Process Chemistry Automation
March 23, 2026 — Dr. Hawkins will contribute to the development of automated reaction sampling technology and Self-Driving Labs.
Telescope Innovations and AGI SDA Launch Technology Development Collaboration
March 16, 2026 — The chemistry technology companies aim to develop a next-generation chemical reactor for automated labs
Telescope Strengthens Investor Communications Strategy
March 12, 2026 — Telescoped has rescoped previously announced digital marketing agreements
Telescope Innovations Installs Second Self-Driving Lab at Pfizer
February 23, 2026 — Installation of second Physical AI platform positions Telescope Innovations to successfully address the rapidly expanding SDL market
Telescope Innovations Delivers Continued Strong Sales Revenue Growth in First Fiscal Quarter 2026
January 30, 2026 — The Company generated revenues of $2.7 million during this period.
Telescope Innovations Expands Lithium Development Infrastructure and Achieves Key Material Validation Milestones
January 27, 2026 — The Company is pleased to provide an update on the progress of its lithium processing portfolio.
Telescope Innovations Plans Expansion of DirectInject-LC™ Technology Ecosystem to Fuel the Physical AI Revolution
January 20, 2026 — Telescope is currently developing two new advanced analytical versions: DirectInject-IC™, and DirectInject-ICP™.
Telescope Innovations Outlines Global Market Opportunity for Self-Driving Labs and the Rising Adoption of Physical AI
January 5, 2026 — Telescope provides a strategic update regarding the accelerating commercial adoption of Self-Driving Labs (SDLs) and the global expansion of Physical AI.
Telescope Innovations Reports Significant Milestones and Financial Results of Fiscal Year 2025
December 23, 2025 — The Company generated revenues of $5.8 million during FY25, with an Adjusted EBITDA loss of $402K
Telescope Innovations Installs Korea’s First Self-Driving Lab for Pharma R&D and Education
December 9, 2025 — Rapid three-week deployment, onsite support from two-time Nobel Laureate, and deep Canada-Korea collaboration underscore accelerating commercial momentum
Telescope Innovations to deliver first Self-Driving Lab for Korea’s largest biopharma manufacturers association
November 17, 2025 — Korea’s leading biopharma association selects Telescope’s Self-Driving Lab to anchor the country’s first AI-driven training hub.
Telescope Innovations conditionally approved for up to $3.36 M in government funding to advance lithium processing technology
November 4, 2025 — Federal support accelerates Telescope’s continued development, demonstration and scale-up of lithium recycling and solid-state battery materials technologies.
Telescope announces debt settlement transaction
October 23, 2025 — The Company has entered into agreements to settle certain outstanding indebtedness through the issuance of 689,654 common shares (each, a “Share”) of the Company (the “Debt Settlement”).
Telescope issues Stock Options and Shares for debt
October 15, 2025 — The Company has granted 1,544,000 incentive stock options (the “Options”) to certain directors, employees and consultants.
Telescope closes final tranche of private placement
October 14, 2025 — Gross proceeds of $1,296,704 were raised in this final tranche.
Telescope Innovations produces battery-grade lithium carbonate from recycled waste streams
September 29, 2025 — Telescope’s proprietary ReCRFT™ process achieves >99.9% pure Li2CO3 from battery recycling brines, with output material sent to Cellmine and University of St Andrews for testing.
Telescope closes initial tranche of private placement
September 15, 2025 — Gross proceeds of $5,203,296 were raised in this initial tranche.
Telescope Innovations appoints Vaso Vlachos as Chief Operating Officer
September 2, 2025 — Ms. Vlachos brings
over 20 years of experience managing automation and analytical technology offerings for the biopharmaceutical and chemical industries.
Telescope Innovations selected to join ALTA: the first US-based lithium technology accelerator
July 24, 2025 — Telescope has been hand-picked to join the inaugural cohort of the Arkansas Lithium Technology Accelerator (ALTA), America’s first lithium technology accelerator.
Telescope Innovations Presents Results of Third Fiscal Quarter 2025
July 16, 2025 — The Company generated revenues of $1.4 million this quarter, with our strongest sales performance for DirectInject-LC.
Telescope Announces Private Placement
July 3, 2025 — The Company will conduct a non-brokered private placement under the Listed Issuer Financing Exemption of common shares of the Company to raise gross proceeds of up to $5,000,000.
Telescope Innovations’ Directors Establish Private Debt Instrument to Accelerate Development of Self-Driving Labs
June 10, 2025 — Telescope Innovations is accelerating Self-driving lab development precisely when most big-pharma labs are budgeting multi-million dollar upgrades.
Telescope Innovations Ships First Samples of Battery-Grade Lithium Sulfide
May 7, 2025 — Lithium sulfide produced using Telescope’s proprietary DualPure™ process is being shipped to industry leaders in Asia and North America.
Telescope Innovations Presents Results of Second Fiscal Quarter 2025
April 23, 2025 — The Company generated revenues of $1.0 million during this quarterly period.
Telescope Innovations to Present at the Planet MicroCap Showcase:VEGAS on April 23, 2025
April 14, 2025 — COO, Dr. Jeffrey W. Sherman of Telescope Innovations Corp will be hosting the presentation and answering questions at the conclusion.
Telescope Provides Update on Private Placement
March 21, 2025 — The Company is offering units (each, a “Unit”) at a price of $0.40 to raise gross proceeds of up to $3,000,000.
Telescope Innovations, Corporation to Present at the Virtual Life Science Investor Forum March 13th
March 11, 2025 — Telescope Innovations invites individual and institutional investors, as well as advisors and analysts, to attend online at VirtualInvestorConferences.com
Telescope Innovations Advances Self-Driving Lab Deployment, Strengthening Industry Impact
February 24, 2025 — Telescope’s Self-Driving Lab (“SDL”) technology integrates AI, robotics, advanced analytics, and chemistry to accelerate research and development.
Telescope Innovations Commences Trading on the Frankfurt Stock Exchange
February 19, 2025 — Telescope Innovations common shares are now listed for trading on the Frankfurt Stock Exchange (“FSE”) under the ticker symbol “J4U”.
Telescope Innovations Founder and CTO, Professor Jason Hein, Honoured with 2025 R. U. Lemieux Award
February 10, 2025 — The R.U. Lemieux Award, presented by the Canadian Society for Chemistry, celebrates excellence in organic chemistry and recognizes distinguished contributions to the field. Professor Hein’s work has advanced the understanding of complex chemical reactions and innovative technologies shaping process chemistry and industrial automation.
Telescope Announces Private Placement
February 4, 2025 — The Company will conduct a non-brokered private placement (the “Offering”) under the Listed Issuer Financing Exemption of units of the Company (each, a “Unit”) to raise gross proceeds of up to $3,000,000.
Telescope Innovations Presents Results of First Fiscal Quarter 2025
January 27, 2025 — The Company generated revenues of $1.2 million during this period (Q3, 2024), and year-to-date revenues surpass entire fiscal year 2023.
Telescope Innovations Demonstrates Production of >99% Pure Lithium Carbonate from Widely Varied North American Brines
January 13, 2025 — Telescope’s proprietary ReCRFT™ process paves the way for on-shore production of battery raw materials.
Telescope Innovations Presents Continued Growth in Fiscal Year 2024
December 23, 2024 — Increased revenues fueled major research and commercialization projects for intelligent automation products and advanced chemical manufacturing.
Telescope Innovations Announces Scientific Publication on AI-Optimized Production of Battery-Grade Lithium Carbonate
October 29, 2024 — AI guides Telescope’s ReCRFT tech to boost efficiency and environmental sustainability of producing battery raw materials.
Telescope Innovations Becomes Certified Systems Integrator of Universal Robots
October 15, 2024 — Certification enables faster development and deployment of Telescope’s Self-Driving Labs.
Telescope Innovations and Altillion Inc. Showcase Proprietary, Simplified Production of Battery-Quality Lithium Carbonate from Brines
September 17, 2024 — Telescope’s proprietary ReCRFT process produces >99.5% pure lithium carbonate from Altillion’s brine concentrates
Telescope Innovations and Standard Lithium Demonstrate Low-Temperature, High-Purity Production of Lithium Sulfide for Solid-State Batteries
August 28, 2024 — Telescope Innovations utilized robotics and artificial intelligence to identify a novel, scalable route to produce lithium sulfide.
Telescope Innovations and Pfizer Sign Master Collaborative Research Agreement
July 31, 2024 — Pfizer and Telescope will develop Self-Driving Laboratories to accelerate pharmaceutical R&D through automation, robotics, and AI.
Telescope Innovations Receives CICE Funding to Pilot Lithium Refinement Technology
July 22, 2024 — Non-dilutive investment will support Telescope’s piloting of its proprietary Recrystallization Refinement Technology, ReCRFT™.
Telescope Innovations Presents Results of Third Fiscal Quarter 2024
July 11, 2024 — The Company generated revenues of $1.2 million during this period (Q3, 2024), and year-to-date revenues surpass entire fiscal year 2023.
Telescope Innovations Joins MaRS: North America’s Largest Urban Innovation Hub
June 24, 2024 — Relative to similar VC-backed ventures, MaRS member companies raise higher capital amounts, having secured over CAD $19B in cumulative investments since 2010.
Telescope Innovations to Participate in Lithium Supply and Battery Raw Materials Conference 2024
June 11, 2024 — Telescope will showcase proprietary lithium refinement technology (ReCRFT™), which generates battery-quality lithium carbonate from brines in a single step.
Telescope Innovations to Showcase DirectInject-LC™ Product and Process IP at METTLER TOLEDO Events
May 13, 2024 — Telescope will feature two proprietary innovations during the New Jersey and Montreal InfoDays hosted by METTLER TOLEDO.
Telescope Innovations Presents Results of Second Fiscal Quarter 2024
April 18, 2024 — The Company generated revenues of $686,205 during this period, driven by strong sales performance of its flagship product, DirectInject-LC™
Telescope Innovations Develops Novel Battery Recycling Technology
April 15, 2024 — Telescope’s new approach isolates lithium and valuable transition metals from battery recycling feeds.
Telescope Innovations and Shimadzu Scientific Instruments Initiate Technology Partnership
February 26, 2024 — Telescope pairs its DirectInject-LC™ technology with Shimadzu’s chemical analysis instrumentation.
Telescope Innovations Strengthens Senior Management: Henry Dubina Appointed as CEO, Dr. Jason Hein as CTO, John Kirincic as CFO, Deborah Cotter as Corporate Secretary
February 15, 2024 — We welcome Henry Dubina as CEO, John Kirincic as CFO, and Deborah Cotter as Corporate Secretary. Jason Hein transitions to CTO.
Mettler Toledo and Telescope Innovations Agree to Globally Distribute Telescope’s Flagship Product, DirectInject-LC™
February 5, 2024 — We have signed a Distribution Agreement with METTLER TOLEDO for Telescope’s online chemistry sampling and analysis product, the DirectInject-LC™.
Telescope Innovations Presents Results of First Fiscal Quarter 2024
January 30, 2024 — The Company generated revenues of $1.50 M for a net income of $215,000, exceeding its prior records.
Telescope Innovations Files Game-Changing Provisional Patent to Purify Battery Materials
January 23, 2024 — Telescope announces it has filed a provisional patent application on a disruptive new technique to purify lithium carbonate.
Telescope Innovations Reports Strong Growth in Fiscal Year 2023
December 22, 2023 — The Company generated revenues of $2.82 M, representing an increase of 375% over the previous fiscal year.
Telescope Innovations Develops New IP for the Production of Battery Materials
December 18, 2023 — Telescope has invented a low-temperature method of generating lithium sulfide from brine-sourced lithium chemicals.
Telescope Innovations and Mott Corporation Initiate Technology Partnership
October 30, 2023 — Telescope and Mott plan to develop and commercialize a novel robotic sampling probe for automated chemistry analysis.
Telescope Innovations Product Deployed by 13 Pharma Giants in First Year
October 4, 2023 — Telescope’s flagship technology, Direct Inject Liquid Chromatography (DILC), has been deployed at 13 of the top 20 pharmaceutical companies in the world.
Telescope Innovations is Granted a Canadian Patent on Chemical Synthesis Route
August 28, 2023 — Telescope’s first Canadian patent describes a scalable manufacturing process to produce pharmaceutically-relevant indole compounds.
Telescope Announces Stock Option Grants
August 3, 2023 — Telescope has granted 800,000 incentive stock options to certain directors of the Company in accordance with the Company’s incentive stock option plan.
Telescope Innovations Receives Accelerator Funding to Develop Carbon-Negative Production of Battery Materials
July 11, 2023 — Canada’s Mining Innovation Commercialization Accelerator (“MICA”) Network will fund Telescope’s efforts to develop lithium carbonate production methods that are carbon-negative.
Telescope Innovations Delivers Continued Profitability in Fiscal Quarter 3, 2023
June 29, 2023 — The Company generated revenues of $1.01M and a net income of $67,847 in Q3, 2023, representing an increase of 500% in net income over the previous quarter.
Telescope at CSC 2023
We will be out in full force at Canada’s largest chemistry conference this year. CSC 2023 is coming to our hometown of Vancouver, and here’s where catch us!
Telescope Reports Profitable Quarter: Fiscal Q2, 2023
April 25, 2023 — Just over one year after securing facilities, assembling a team, and outfitting a research laboratory, the Company delivered its first profitable quarter.
Telescope Reports First Fiscal Quarter 2023 Results
February 8, 2023 — Telescope is revenue-positive for a second consecutive quarter. Catch us at a series of upcoming investor events and technical conferences.
Telescope Presents 2022 Fiscal Year Highlights and Investor Update
January 23, 2023 — Telescope reports revenue in first full year of operation, a new project with Aqualung Carbon Capture, and upcoming events.
Telescope Announces Closing of $1.46 Million Non-brokered Private Placement
November 10, 2022 — Telescope intends to use the net proceeds from the Offering for working capital and general corporate purposes.
Takeaways From our Press Release on NRCan Project
October 31, 2022 — View PR highlights and watch the video on how this project supports Telescope’s goals
Telescope Announces Engagement with Natural Resources Canada to Develop Lithium Refinement Technology
October 24, 2022 — Telescope will collaborate with NRCan to build an autonomous, self-driving experimental platform for lithium refinement.
Second Nobel Prize Won by Telescope Innovations Advisor
October 6, 2022 — K. Barry Sharpless, a member of Telescope’s Scientific Advisory Board, was awarded the 2022 Nobel Prize in Chemistry.
